1. Academic Validation
  2. N,N-dibenzyl-N'-benzylidenehydrazines: potent competitive glucose-6-phosphatase catalytic enzyme inhibitors

N,N-dibenzyl-N'-benzylidenehydrazines: potent competitive glucose-6-phosphatase catalytic enzyme inhibitors

  • Bioorg Med Chem Lett. 2001 Aug 20;11(16):2165-7. doi: 10.1016/s0960-894x(01)00395-x.
P Madsen 1 P Jakobsen N Westergaard
Affiliations

Affiliation

  • 1 Medicinal Chemistry Research, Novo Nordisk A/S, Novo Nordisk Discovery, Novo Nordisk Park, DK-2760, Maaloev, Denmark. pem@novonordisk.com
Abstract

A novel class of N,N-dibenzyl-N'-benzylidenehydrazines as potent and competitive glucose-6-phosphatase catalytic site inhibitors are described. Optimisation of this series identified compounds with IC(50) values as low as 170 nM.

Figures
Products